WPI 1119 (Mirtazapine 45 mg)
Pill with imprint WPI 1119 is White, Elliptical / Oval and has been identified as Mirtazapine 45 mg. It is supplied by Watson Pharmaceuticals.
Mirtazapine is used in the treatment of major depressive disorder; anxiety; insomnia; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 1119
Mirtazapine
- Imprint:
- WPI 1119
- Strength:
- 45 mg
- Color:
- White
- Size:
- 16.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Pharmaceuticals
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 63874-1155 | Altura Pharmaceuticals Inc. (repackager) |
More about mirtazapine
- Mirtazapine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 951 Reviews
- Drug class: tetracyclic antidepressants
- FDA Alerts (3)
Consumer resources
- Mirtazapine
- Mirtazapine Orally Disintegrating Tablets
- Mirtazapine Tablets
- Mirtazapine (Advanced Reading)
Other brands: Remeron, Remeron SolTab
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
